Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Merck to acquire Revolution Medicines amid growth shift

PRIVATEAug 12, 2026•about 3 hours ago

Acquiring Company

Merck

Acquired Company

Revolution Medicines

Pembroke Pines

Redwood CityManufacturingHealthcareBiotechnologyHealthcareHealth CareTherapeuticsPharmaceutical

Description

Merck is looking to acquire Revolution Medicines, recognizing the latter's potential in oncology and addressing the challenges posed by Keytruda's patent expiry. Revolution Medicines has demonstrated impressive clinical data with daraxonrasib, making it an attractive target for Merck's ongoing transformation strategy. The acquisition is seen as a strategic move to enhance Merck's growth portfolio amidst significant market pressures.

Company Information

Company

Merck

Location

19700 STIRLING ROAD

Pembroke Pines, Florida, United States

About

For over 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Don't miss Merck's next move

Get an email the moment Merck makes an acquisition, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Merck's next move

Learn about Strategic plan

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Revolution Medicines?

Revolution Medicines was acquired by Merck, based in Pembroke Pines. The deal was reported on August 12, 2026. Merck is privately held and operates in Manufacturing.

When did Merck acquire Revolution Medicines?

Merck's acquisition of Revolution Medicines was reported on August 12, 2026. Merck is looking to acquire Revolution Medicines, recognizing the latter's potential in oncology and addressing the challenges posed by Keytruda's patent expiry. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Revolution Medicines do?

Revolution Medicines, Inc. Revolution Medicines is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. It is publicly traded (RVMD), operating in Biotechnology, and is based in Redwood City.